Do you often suffer from acne? Take heart a potential vaccine that targets the bacterial toxins may soon be on the anvil say researchers. Instead of invading pathogens the new vaccine would be the first to target bacteria already in human skin. The researchers demonstrated that antibodies to a toxin secreted from bacteria in acne vulgaris can reduce inflammation in human acne lesions. Once validated by a large-scale clinical trial the potential impact of our findings is huge for the hundreds of millions of individuals suffering from acne vulgaris explained lead investigator Chun-Ming Huang from the University of California-San Diego US. An
